Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Awada

Showing results (31-40 of 1,005) with videos related to

Pageof 101
Sort By:
Expert Opinion on Pharmacotherapy|December 9, 2016
Advances in chemical pharmacotherapy to manage advanced breast cancerAndrea Gombos, Ahmad Awada
Advances in Therapy|October 25, 2011
Survival benefit of eribulin mesylate in heavily pretreated metastatic breast cancer: what next?Philippe Aftimos, Ahmad Awada
Critical Reviews in Oncology/Hematology|March 15, 2011
Milestones in the use of chemotherapy for the management of non-small cell lung cancer (NSCLC)Jean Klastersky, Ahmad Awada
Revue Medicale De Bruxelles|January 24, 1998
[Gemcitabine: a new chemotherapy agent for solid cancers]J Klastersky, A Awada
Current Opinion in Oncology|July 24, 2019
Checkpoints inhibitors in the (neo)adjuvant setting of solid tumors: lessons learnt and perspectivesNuria Kotecki, Ahmad Awada
Morphologie : Bulletin De L'Association Des Anatomistes|March 23, 2010
[Michel Latarjet (1913-1999), surgeon explorer!]T Awada, P Liverneaux
Critical Reviews in Oncology/Hematology|March 5, 2025
Molecular oncology of iodine refractory thyroid cancer current therapies and perspectiveFrançois Cherifi, Ahmad Awada
Joint Bone Spine|August 15, 2006
Late onset Behçet's diseaseNelly Ziadé, Hassane Awada
Critical Reviews in Oncology/Hematology|March 16, 2010
Prevention of febrile neutropenia in chemotherapy-treated cancer patients: Pegylated versus standard myeloid colony stimulating factors. Do we have a choice?Jean Klastersky, Ahmad Awada
Micromachines|December 2, 2020
Effect of pH and Nanoparticle Capping Agents on Cr (III) Monitoring in Water: A Kinetic Way to Control the Parameters of Ultrasensitive Environmental DetectorsChawki Awada, Hassan Traboulsi
Pageof 101

Showing results (31-40 of 1,005) with videos related to

Sort By:
Pageof 101
Expert Opinion on Pharmacotherapy|December 9, 2016
Advances in chemical pharmacotherapy to manage advanced breast cancerAndrea Gombos, Ahmad Awada
Advances in Therapy|October 25, 2011
Survival benefit of eribulin mesylate in heavily pretreated metastatic breast cancer: what next?Philippe Aftimos, Ahmad Awada
Critical Reviews in Oncology/Hematology|March 15, 2011
Milestones in the use of chemotherapy for the management of non-small cell lung cancer (NSCLC)Jean Klastersky, Ahmad Awada
Revue Medicale De Bruxelles|January 24, 1998
[Gemcitabine: a new chemotherapy agent for solid cancers]J Klastersky, A Awada
Current Opinion in Oncology|July 24, 2019
Checkpoints inhibitors in the (neo)adjuvant setting of solid tumors: lessons learnt and perspectivesNuria Kotecki, Ahmad Awada
Morphologie : Bulletin De L'Association Des Anatomistes|March 23, 2010
[Michel Latarjet (1913-1999), surgeon explorer!]T Awada, P Liverneaux
Critical Reviews in Oncology/Hematology|March 5, 2025
Molecular oncology of iodine refractory thyroid cancer current therapies and perspectiveFrançois Cherifi, Ahmad Awada
Joint Bone Spine|August 15, 2006
Late onset Behçet's diseaseNelly Ziadé, Hassane Awada
Critical Reviews in Oncology/Hematology|March 16, 2010
Prevention of febrile neutropenia in chemotherapy-treated cancer patients: Pegylated versus standard myeloid colony stimulating factors. Do we have a choice?Jean Klastersky, Ahmad Awada
Micromachines|December 2, 2020
Effect of pH and Nanoparticle Capping Agents on Cr (III) Monitoring in Water: A Kinetic Way to Control the Parameters of Ultrasensitive Environmental DetectorsChawki Awada, Hassan Traboulsi
Pageof 101